Dr. Strassman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1206 N Riverside Dr
Espanola, NM 87532Phone+1 505-747-0102Fax+1 505-758-9758
Education & Training
University of California Davis HealthResidency, Psychiatry, 1977 - 1981
Albert Einstein College of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1978 - Present
NM State Medical License 1985 - 2025- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 565 citationsPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyMichael P. Bogenschutz, Alyssa A. Forcehimes, Jessica Pommy, Claire E. Wilcox, Paulo Cesar Ribeiro Barbosa
Journal of Psychopharmacology. 2015-01-13 - 45 citationsHallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects.Rick J. Strassman
The Journal of Nervous and Mental Disease. 1995-03-01 - 154 citationsDose-Response Study of N,N-Dimethyltryptamine in Humans: I. Neuroendocrine, Autonomic, and Cardiovascular EffectsRick J. Strassman, Clifford Qualls
Archives of General Psychiatry. 1994-02-01
Press Mentions
UNM Health Sciences Researchers to Test Psychedelic Drugs as Treatments for Depression, PTSD and MoreJuly 22nd, 2024- New Research Exploring DMT as a Treatment for StrokeOctober 4th, 2022
- The Brave New Future of Mental Health CareOctober 6th, 2021
- Join now to see all
Grant Support
- Serotonergic Mediation Of N,N-Dimethyltryptamine EffectsNational Center For Research Resources1996
- Psychopharmacology And Neuroendocrinology Of N, N-DimethyltryptamineNational Center For Research Resources1996
- Human Psychopharmacology Of LSD 25National Center For Research Resources1996
- Acute Tolerance To N,N-DimethyltryptamineNational Center For Research Resources1996
- Endogenous Opioids In Mediating The Effects Of DimethyltryptamineNational Center For Research Resources1994–1996
- Tryptamine Hallucinogens--NeuropsychopharmacologyNational Institute On Drug Abuse1994
- Serotonergic Mediation Of N,N-Dimethyltryptamine Effects In HumansNational Center For Research Resources1994
- Magnetic Resonance Assessment Of Tryptamine Hallucinogens In HumansNational Center For Research Resources1994
- Human Psychopharmacology And Neuroendocrinology Of N, N-DimethyltryptamineNational Center For Research Resources1993–1994
- Acute Tolerance To N,N-Dimethyltryptamine In HumansNational Center For Research Resources1993–1994
- Tryptamine Hallucinogens--Human NeuropsychopharmacologyNational Institute On Drug Abuse1993
- Endogenous Opioids In Mediating The Effects Of Dimethyltryptamine In HumansNational Center For Research Resources1993
- EEG Effects Of N,N-Dimethyltryptamine In Normal VolunteersNational Center For Research Resources1993
- Human Psychopharmacology &Neuroendocrinology Of DMTNational Institute On Drug Abuse1990–1991
- Melatonin Dynamics, Suppressive Effects Of Light In SADNational Center For Research Resources1990
- Behavioral And Neuroendocrine Effects Of Bright Light SuppressionNational Center For Research Resources1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
